# Pharmacokinetic Study of Doxorubicin in Children With Cancer

> **NCT01095926** · PHASE2 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 101 (actual)

## Conditions studied

- Wilms Tumor
- Neuroblastoma
- Soft Tissue Sarcoma
- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** doxorubicin

## Key facts

- **NCT ID:** NCT01095926
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-05
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2013-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01095926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01095926, "Pharmacokinetic Study of Doxorubicin in Children With Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01095926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*